BioSpecifics Technologies

YTD

ALL

Why Robinhood?

You can watch BSTC and buy or sell other stocks, ETFs, and their options commission-free!

About BSTC

BioSpecifics Technologies Corp., a biopharmaceutical company, is engaged in the development of an injectable collagenase for various indications primarily in the United States. It provides injectable collagenase under the XIAFLEX name for the treatment of Dupuytren’s contracture and Peyronie’s disease.

CEO

Blaise A Coleman, MBA

CEOBlaise A Coleman, MBA

Employees

—

Employees—

Headquarters

Lynbrook, New York

HeadquartersLynbrook, New York

Founded

1990

Founded1990

Employees

—

Employees—

BSTC Key Statistics

Market cap

650.25M

Market cap650.25M

Price-Earnings ratio

37.55

Price-Earnings ratio37.55

Dividend yield

—

Dividend yield—

Average volume

76.20K

Average volume76.20K

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$89.15

52 Week high$89.15

52 Week low

$42.00

52 Week low$42.00